These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1100 related items for PubMed ID: 18640809

  • 1. Axillary recurrence rate after tumour negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study.
    Bulte CS, van der Heiden-van der Loo M, Hennipman A.
    Eur J Surg Oncol; 2009 Jan; 35(1):25-31. PubMed ID: 18640809
    [Abstract] [Full Text] [Related]

  • 2. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years.
    Groetelaers RP, van Berlo CL, Nijhuis PH, Schapers RF, Gerritsen HA.
    Eur J Surg Oncol; 2009 Feb; 35(2):159-63. PubMed ID: 18789841
    [Abstract] [Full Text] [Related]

  • 3. Axillary recurrence rate after negative sentinel node biopsy in breast cancer: three-year follow-up of the Swedish Multicenter Cohort Study.
    Bergkvist L, de Boniface J, Jönsson PE, Ingvar C, Liljegren G, Frisell J, Swedish Society of Breast Surgeons.
    Ann Surg; 2008 Jan; 247(1):150-6. PubMed ID: 18156935
    [Abstract] [Full Text] [Related]

  • 4. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
    Yegiyants S, Romero LM, Haigh PI, DiFronzo LA.
    Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
    [Abstract] [Full Text] [Related]

  • 5. [Critical study of our initial experience of 993 sentinel node biopsies for breast surgery].
    Martel P, Capdet J, Méry E, Zerdoud S, Ferron G, Rafii A, Roché H, Querleu D.
    Bull Cancer; 2008 Jun; 95(7):763-72. PubMed ID: 18755653
    [Abstract] [Full Text] [Related]

  • 6. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis.
    Torrenga H, Fabry H, van der Sijp JR, van Diest PJ, Pijpers R, Meijer S.
    J Surg Oncol; 2004 Oct 01; 88(1):4-7; discussion 7-8. PubMed ID: 15384064
    [Abstract] [Full Text] [Related]

  • 7. Treatment of 100 patients with sentinel node-negative breast cancer without further axillary dissection.
    Roumen RM, Kuijt GP, Liem IH, van Beek MW.
    Br J Surg; 2001 Dec 01; 88(12):1639-43. PubMed ID: 11736979
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Erratum to: Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up.
    Kiluk JV, Ly QP, Santillan AA, Meade T, Ramos D, Reintgen DS, Dessureault S, Davis M, Shamehdi C, Cox CE.
    Ann Surg Oncol; 2010 Feb 01; 17(2):552-7. PubMed ID: 19957043
    [Abstract] [Full Text] [Related]

  • 10. [Negative sentinel node in breast cancer patients a good indicator for continued absence of axillary metastases].
    Meijer S, Torrenga H, van der Sijp JR.
    Ned Tijdschr Geneeskd; 2002 May 18; 146(20):942-6. PubMed ID: 12051063
    [Abstract] [Full Text] [Related]

  • 11. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.
    Langer I, Guller U, Viehl CT, Moch H, Wight E, Harder F, Oertli D, Zuber M.
    Ann Surg Oncol; 2009 Dec 18; 16(12):3366-74. PubMed ID: 19760047
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study.
    Reed J, Rosman M, Verbanac KM, Mannie A, Cheng Z, Tafra L.
    J Am Coll Surg; 2009 Mar 18; 208(3):333-40. PubMed ID: 19317993
    [Abstract] [Full Text] [Related]

  • 14. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
    Husted Madsen A, Haugaard K, Soerensen J, Bokmand S, Friis E, Holtveg H, Peter Garne J, Horby J, Christiansen P.
    Breast; 2008 Apr 18; 17(2):138-47. PubMed ID: 17928226
    [Abstract] [Full Text] [Related]

  • 15. Axillary recurrence rate in breast cancer patients with negative sentinel lymph node.
    Snoj M, Bracko M, Zagar I.
    Croat Med J; 2005 Jun 18; 46(3):377-81. PubMed ID: 15861515
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Patients with breast cancer and negative sentinel lymph node biopsy without additional axillary lymph node dissection: a follow-up study of up to 5 years.
    Domènech A, Benitez A, Bajén MT, Pla MJ, Gil M, Martín-Comín J.
    Oncology; 2007 Jun 18; 72(1-2):27-32. PubMed ID: 17998787
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.